In vivo regulation of matrix vesicle concentration and enzyme activity during primary bone formation.
In vivo regulation of matrix vesicles (MV) during primary bone formation was examined using tibial marrow ablation in rats as the experimental model. The effects of bone-bonding and nonbonding implants on the number of MV/micron 2 of matrix and the alkaline phosphatase (ALPase) and phospholipase A2 (PA2) activities of MV-enriched microsomes (MVEM) isolated from the healing bone were studied. MV concentration, ALPase, and PA2 were increased by bone-bonding implants by day 3 post-surgery; a similar effect was seen in the contralateral limb, but at a lower magnitude. Nonbonding implants had no effect at day 3 and decreased MV concentration and PA2 activity at later time points; the same behavior was observed in the contralateral limb. These results demonstrate that MVs are influenced in a differential manner by implant materials, both locally and systemically, and can be regulated during primary mineralization.
Schwartz
Z
Z
Hebrew University, Jerusalem.
Swain
L
L
Sela
J
J
Gross
U
U
Amir
D
D
Kohavi
D
D
Muller-Mai
C
C
Boyan
B
B
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001672:Biocompatible Materials; D001857:Bone Matrix / Q000201:enzymology / Q000648:ultrastructure*; D002516:Ceramics; D008297:Male; D008861:Microsomes / Q000201:enzymology; D010012:Osteogenesis / Q000502:physiology*; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D019736:Prostheses and Implants; D051381:Rats; D013193:Stainless Steel; D014025:Titanium
D001672:Biocompatible Materials; D013193:Stainless Steel; D014025:Titanium; D010741:Phospholipases A; D054467:Phospholipases A2; D000469:Alkaline Phosphatase